52Mn-labelled Beta-cyclodextrin for Melanoma Imaging: A Proof-of-concept Preclinical Study.
Saved in:
| Title: | 52Mn-labelled Beta-cyclodextrin for Melanoma Imaging: A Proof-of-concept Preclinical Study. |
|---|---|
| Authors: | Képes Z; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; kepes.zita@med.unideb.hu.; Gyula Petrányi Doctoral School of Clinical Immunology and Allergology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Szabó JP; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Kálmán-Szabó I; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Gyula Petrányi Doctoral School of Clinical Immunology and Allergology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Sass T; Department of Surgery, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Esze R; Division of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Opposits G; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Jószai I; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Szikra D; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Fenyvesi F; Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary., Hajdu I; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Trencsényi G; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Gyula Petrányi Doctoral School of Clinical Immunology and Allergology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. |
| Source: | In vivo (Athens, Greece) [In Vivo] 2024 Nov-Dec; Vol. 38 (6), pp. 2591-2600. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39477386 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: <superscript>52</superscript>Mn-labelled Beta-cyclodextrin for Melanoma Imaging: A Proof-of-concept Preclinical Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Képes+Z%22">Képes Z</searchLink>; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; kepes.zita@med.unideb.hu.; Gyula Petrányi Doctoral School of Clinical Immunology and Allergology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Szabó+JP%22">Szabó JP</searchLink>; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Kálmán-Szabó+I%22">Kálmán-Szabó I</searchLink>; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Gyula Petrányi Doctoral School of Clinical Immunology and Allergology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Sass+T%22">Sass T</searchLink>; Department of Surgery, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Esze+R%22">Esze R</searchLink>; Division of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Opposits+G%22">Opposits G</searchLink>; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Jószai+I%22">Jószai I</searchLink>; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Szikra+D%22">Szikra D</searchLink>; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Fenyvesi+F%22">Fenyvesi F</searchLink>; Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Hajdu+I%22">Hajdu I</searchLink>; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Trencsényi+G%22">Trencsényi G</searchLink>; Division of Nuclear Medicine and Translational Imaging, Department of Medical Imaging, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Gyula Petrányi Doctoral School of Clinical Immunology and Allergology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228806809%22">In vivo (Athens, Greece)</searchLink> [In Vivo] 2024 Nov-Dec; Vol. 38 (6), pp. 2591-2600. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22International+Institute+of+Anticancer+Research%22">International Institute of Anticancer Research </searchLink><i>Country of Publication: </i>Greece <i>NLM ID: </i>8806809 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1791-7549 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220258851X%22">0258851X </searchLink><i>NLM ISO Abbreviation: </i>In Vivo <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39477386 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.21873/invivo.13735 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2591 Titles: – TitleFull: 52Mn-labelled Beta-cyclodextrin for Melanoma Imaging: A Proof-of-concept Preclinical Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Képes Z – PersonEntity: Name: NameFull: Szabó JP – PersonEntity: Name: NameFull: Kálmán-Szabó I – PersonEntity: Name: NameFull: Sass T – PersonEntity: Name: NameFull: Esze R – PersonEntity: Name: NameFull: Opposits G – PersonEntity: Name: NameFull: Jószai I – PersonEntity: Name: NameFull: Szikra D – PersonEntity: Name: NameFull: Fenyvesi F – PersonEntity: Name: NameFull: Hajdu I – PersonEntity: Name: NameFull: Trencsényi G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2024 Nov-Dec Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1791-7549 Numbering: – Type: volume Value: 38 – Type: issue Value: 6 Titles: – TitleFull: In vivo (Athens, Greece) Type: main |
| ResultId | 1 |